Aristeia Capital’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$521K Sell
5,035
-3,031
-38% -$271K 0.01% 415
2026
Q1
$579K Buy
8,066
+1,874
+30% +$144K 0.01% 334
2025
Q4
$491K Buy
+6,192
New +$488K 0.01% 329

Other funds holding CVS

Aristeia Capital's CVS Position: Q2 2026 in Review

Aristeia Capital reduced its CVS Health (CVS) stake by 38% in Q2 2026, selling an estimated $271K and leaving 5,035 shares worth $521K. The position accounts for 0.01% of the portfolio, ranked #415.

Aristeia Capital first reported a position in CVS in Q4 2025 and has held it in 3 quarters since. The position peaked at $579K in Q1 2026. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Aristeia Capital held 5,035 shares of CVS Health worth $521K as of Q2 2026.
  • Aristeia Capital sold 3,031 CVS Health shares in Q2 2026, an estimated $271K.
  • CVS Health made up 0.01% of Aristeia Capital's portfolio in Q2 2026, its #415 holding.
  • Aristeia Capital first reported a position in CVS Health in Q4 2025 and has held it in 3 quarters since.
  • Aristeia Capital's CVS Health position peaked at $579K in Q1 2026.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Aristeia Capital's 13F filing for Q2 2026, filed 14 Aug 2026.